Biogen Inc (NASDAQ:BIIB)
| 261.58 Delayed Data As of Oct 05 |  -5.76 / -2.15%Today’s Change | 187.16 Today|||52-Week Range 290.76 | +9.03% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 267.45 |
| Today’s open | 265.28 |
| Day’s range | 257.51 - 266.43 |
| Volume | 1,573,701 |
| Average volume (3 months) | 1,257,175 |
| Market cap | $39.1B |
Data as of 4:00pm ET, 10/05/2022
Growth & Valuation
| Earnings growth (last year) | -58.03% |
| Earnings growth (this year) | -14.43% |
| Earnings growth (next 5 years) | -3.25% |
| Revenue growth (last year) | -15.81% |
| P/E ratio | 18.7 |
| Price/Sales | 3.45 |
| Price/Book | 3.60 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +13.46 | +6.56% |
| MRNAModerna Inc | -0.05 | -0.04% |
| ---- | ||
| BMRNBiomarin Pharmaceuti... | +1.62 | +1.84% |
Data as of 4:00pm ET, 10/05/2022
Financials
| Next reporting date | October 25, 2022 |
| EPS forecast (this quarter) | $4.13 |
| Annual revenue (last year) | $10.4B |
| Annual profit (last year) | $1.6B |
| Net profit margin | 14.96% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
